[ad_1]
Reuters quoted a senior official at Beximco Pharmaceuticals, one of the leading drug makers in Bangladesh, as saying that the company will start producing Remisdiver this month.
Gilliad said she would donate the first 1.5 million doses of the drug and was focusing on making the drug available at an affordable price to as many people as possible after approval.
He added that he is working to establish a consortium with various partners to maximize the property’s global supply, and the property’s production needs rare raw materials and special manufacturing capabilities.
The company also said it is in an advanced stage of talks with the United Nations Children’s Fund (UNICEF) to deliver the drug using the organization’s distribution networks.
“>
Given that many countries suffer from an outbreak of coronavirus, there is great interest in the remedial drug, as there are currently no approved treatments or vaccines for Covid-19, a respiratory disorder caused by the emerging Corona virus.
Last year, Gilliad obtained approval from the U.S. Food and Drug Administration for the emergency use of the remedial drug as a treatment for Covid-19 after the company provided data showing that the drug had helped the disease. .
The company said Tuesday that it is negotiating long-term licenses with various pharmaceutical companies in India and Pakistan for the production of remedies for developing countries and that it will provide technology to aid production.
Reuters quoted a senior official at Beximco Pharmaceuticals, one of the leading drug makers in Bangladesh, as saying that the company will start producing Remisdiver this month.
Gilliad said she would donate the first 1.5 million doses of the drug and was focusing on making the drug available at an affordable price to as many people as possible after approval.
He added that he is working to establish a consortium with various partners to maximize the property’s global supply, and the property’s production needs rare raw materials and special manufacturing capabilities.
The company also said it is in an advanced stage of talks with the United Nations Children’s Fund (UNICEF) to deliver the drug using the organization’s distribution networks.
